Keloid Treatment Market- Global Industry Analysis and forecast 2023 – 2029


Keloid Treatment Market size was valued US$ 4.55 Bn. in 2022 and the total revenue is expected to grow at 5.3% from 2023 to 2029, reaching nearly US$ 6.53 Bn.

Keloid Treatment Market Defination

Keloid treatment contains corticosteroid injections or intraregional steroids in which they are good but quite pain-causing. Laser treatment of keloid includes the pulsed type dye laser that can be good at flattening the keloids & appearing them little less red.Global Keloid Treatment MarketTo know about the Research Methodology :- Request Free Sample Report

The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis.

Keloid Treatment Market Dynamics

The MMR report contains a detailed study of factors that will drive and restrain the growth of the keloid treatment market. Such as, the upsurge in expenditure on personal care products significantly contributes towards the development of the keloid treatment market globally. Keloids can appear anywhere on the body and affect an expected 10-15% of all wounds. According to the National Institute of Health, Keloid scars are most common in people with the age group of 10 years to 30 years. Keloid scars are usually seen in Asians, African Americans, or Hispanic descents. Expanding awareness regarding appearance and looks among people is the major fueling factor for the global keloid treatment market.

The availability of technologically advanced products like laser instruments, at lower costs is expected to boost their adoption, coupled with a significant presence of target population in the APAC is driving market expansion. Such as, there are more than 10 million cases each year in India only. As per the WHO (World Health Organization), in India, above 1,000,000 people are moderately burnt yearly.

Companies in the global keloid treatment market are more focused on enhancing their product and service offerings through many strategic approaches. Such as, in 2022, Xstrahl Medical, one of the major companies in superficial radiotherapy devices to treat dermatological conditions and, launched its newest superficial radiotherapy treatment system.

Keloid Treatment Market Segment Analysis

The MMR report will provide an accurate prediction of the contribution of the various segments to the growth of the keloid treatment market size. By end-user, the hospitals segment was valued at US$ xx.24 Mn in 2022 and is expected to reach US$ xx.43 Mn by 2029 at a CAGR of xx.34% during the forecast period. This is because of high patient footfalls in the hospitals for any treatment as hospitals are highly preferred over other treatment centers.

Keloid Treatment Market Regional Analysis

North America is expected to continue to hold the largest xx.76% share in keloid treatment market because of the high prevalence skin-related disorders and trauma coupled with the relatively high and easy availability as well as the adoption of new technologies, products, and treatment alternatives. For example, there are about 93 million people in the U.S. suffering from scars, out of which about 169 million scars can be characterized as hypertrophic and keloid scars. Yearly, 1.1 million burn injuries need medical attention in the U.S.

The objective of the report is to present a comprehensive analysis of the Global Keloid Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants.

PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Keloid Treatment Market dynamics, structure by analyzing the market segments and projects the Global Keloid Treatment Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Keloid Treatment Market make the report investor’s guide.

Keloid Treatment Market Scope:Inquire Before Buying






Global Keloid Treatment Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2017 to 2022
Market Size in 2022:
US $ 4.55 Bn.




Forecast Period 2023 to 2029 CAGR:
5.3%
Market Size in 2029:
US $ 6.53 Bn.




 Segments Covered:
by Treatment Type
•Occlusive dressing
• Compression therapy
• Cryosurgery
• Excision
• Radiation therapy
• Laser therapy
• Interferon therapy
• Intralesional corticosteroid injection
• Others




by End User
• Hospitals
• Dermatology clinics
• Ambulatory surgical centers
• Others






Keloid Treatment Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Keloid Treatment Market Key Players are:

• Revitol Corporation Inc.
• Xstrahl Medical
• GlaxoSmithKline plc.
• Bristol-Myers Squibb Company
• Sensus Healthcare, Inc
• Novartis AG,
• Renovo Group plc.
• Bausch Health
• Scarless Laboratories Inc.
• Galena Biopharma, Inc.
• RXi Pharmaceuticals, Inc.
• Avita Medical
• Perrigo Company
• Soliton, Inc
• Pacific World Corporation
• Valeant Pharmaceuticals International Inc.
• Sonoma Pharmaceuticals
• Cynosure
• Scar Heal
• NewMedical Technology

Frequently Asked questions

1. Which region has the largest share in Global Keloid Treatment Market?
Ans: Asia Pacific region held the highest share in 2022.

2. What is the growth rate of Global Keloid Treatment Market?
Ans: The Global Keloid Treatment Market is growing at a CAGR of 5.3% during forecasting period 2023-2029.

3. What is scope of the Global Keloid Treatment Market report?
Ans: Global Keloid Treatment Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Keloid Treatment Market?
Ans: The important key players in the Global Keloid Treatment Market are – Revitol Corporation Inc.,Xstrahl Medical, GlaxoSmithKline plc.,Bristol-Myers Squibb Company,Sensus Healthcare, Inc,Novartis AG,Renovo Group plc.

5. What is the study period of this Market?
Ans: The Global Keloid Treatment Market is studied from 2022 to 2029. 




Global Keloid Treatment Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources

3. Executive Summary: Global Keloid Treatment Market Size, by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies

5. Supply Side and Demand Side Indicators
6. Global Keloid Treatment Market Analysis and Forecast
6.1. Keloid Treatment Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Keloid Treatment Market Analysis and Forecast, By End User
7.1. Introduction and Definition
7.2. Key Findings
7.3. Keloid Treatment Market Value Share Analysis, By End User
7.4. Keloid Treatment Market Size (US$ Bn) Forecast, By End User
7.5. Keloid Treatment Market Analysis, By End User
7.6. Keloid Treatment Market Attractiveness Analysis, By End User

8. Global Keloid Treatment Market Analysis and Forecast, By Treatment Type
8.1. Introduction and Definition
8.2. Key Findings
8.3. Keloid Treatment Market Value Share Analysis, By Treatment Type
8.4. Keloid Treatment Market Size (US$ Bn) Forecast, By Treatment Type
8.5. Keloid Treatment Market Analysis, By Treatment Type
8.6. Keloid Treatment Market Attractiveness Analysis, By Treatment Type

9. Global Keloid Treatment Market Analysis, by Region
9.1. Keloid Treatment Market Value Share Analysis, by Region
9.2. Keloid Treatment Market Size (US$ Bn) Forecast, by Region
9.3. Keloid Treatment Market Attractiveness Analysis, by Region

10. North America Keloid Treatment Market Analysis
10.1. Key Findings
10.2. North America Keloid Treatment Market Overview
10.3. North America Keloid Treatment Market Value Share Analysis, By End User
10.4. North America Keloid Treatment Market Forecast, By End User
10.4.1. Hospitals
10.4.2. Dermatology clinics
10.4.3. Ambulatory surgical centers
10.4.4. Others
10.5. North America Keloid Treatment Market Value Share Analysis, By Treatment Type
10.6. North America Keloid Treatment Market Forecast, By Treatment Type
10.6.1. Occlusive dressing
10.6.2. Compression therapy
10.6.3. Cryosurgery
10.6.4. Excision
10.6.5. Radiation therapy
10.6.6. Laser therapy
10.6.7. Interferon therapy
10.6.8. Intralesional corticosteroid injection
10.6.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
10.7. North America Keloid Treatment Market Value Share Analysis, by Country
10.8. North America Keloid Treatment Market Forecast, by Country
10.8.1. U.S.
10.8.2. Canada
10.9. North America Keloid Treatment Market Analysis, by Country
10.10. U.S. Keloid Treatment Market Forecast, By End User
10.10.1. Hospitals
10.10.2. Dermatology clinics
10.10.3. Ambulatory surgical centers
10.10.4. Others
10.11. U.S. Keloid Treatment Market Forecast, By Treatment Type
10.11.1. Occlusive dressing
10.11.2. Compression therapy
10.11.3. Cryosurgery
10.11.4. Excision
10.11.5. Radiation therapy
10.11.6. Laser therapy
10.11.7. Interferon therapy
10.11.8. Intralesional corticosteroid injection
10.11.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
10.12. Canada Keloid Treatment Market Forecast, By End User
10.12.1. Hospitals
10.12.2. Dermatology clinics
10.12.3. Ambulatory surgical centers
10.12.4. Others
10.13. Canada Keloid Treatment Market Forecast, By Treatment Type
10.13.1. Occlusive dressing
10.13.2. Compression therapy
10.13.3. Cryosurgery
10.13.4. Excision
10.13.5. Radiation therapy
10.13.6. Laser therapy
10.13.7. Interferon therapy
10.13.8. Intralesional corticosteroid injection
10.13.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
10.14. North America Keloid Treatment Market Attractiveness Analysis
10.14.1. By End User
10.14.2. By Treatment Type
10.15. PEST Analysis
10.16. Key Trends
10.17. Key Developments

11. Europe Keloid Treatment Market Analysis
11.1. Key Findings
11.2. Europe Keloid Treatment Market Overview
11.3. Europe Keloid Treatment Market Value Share Analysis, By End User
11.4. Europe Keloid Treatment Market Forecast, By End User
11.4.1. Hospitals
11.4.2. Dermatology clinics
11.4.3. Ambulatory surgical centers
11.4.4. Others
11.5. Europe Keloid Treatment Market Value Share Analysis, By Treatment Type
11.6. Europe Keloid Treatment Market Forecast, By Treatment Type
11.6.1. Occlusive dressing
11.6.2. Compression therapy
11.6.3. Cryosurgery
11.6.4. Excision
11.6.5. Radiation therapy
11.6.6. Laser therapy
11.6.7. Interferon therapy
11.6.8. Intralesional corticosteroid injection
11.6.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
11.7. Europe Keloid Treatment Market Value Share Analysis, by Country
11.8. Europe Keloid Treatment Market Forecast, by Country
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Europe Keloid Treatment Market Analysis, by Country
11.10. Germany Keloid Treatment Market Forecast, By End User
11.10.1. Hospitals
11.10.2. Dermatology clinics
11.10.3. Ambulatory surgical centers
11.10.4. Others
11.11. Germany Keloid Treatment Market Forecast, By Treatment Type
11.11.1. Occlusive dressing
11.11.2. Compression therapy
11.11.3. Cryosurgery
11.11.4. Excision
11.11.5. Radiation therapy
11.11.6. Laser therapy
11.11.7. Interferon therapy
11.11.8. Intralesional corticosteroid injection
11.11.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
11.12. U.K. Keloid Treatment Market Forecast, By End User
11.12.1. Hospitals
11.12.2. Dermatology clinics
11.12.3. Ambulatory surgical centers
11.12.4. Others
11.13. U.K. Keloid Treatment Market Forecast, By Treatment Type
11.13.1. Occlusive dressing
11.13.2. Compression therapy
11.13.3. Cryosurgery
11.13.4. Excision
11.13.5. Radiation therapy
11.13.6. Laser therapy
11.13.7. Interferon therapy
11.13.8. Intralesional corticosteroid injection
11.13.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
11.14. France Keloid Treatment Market Forecast, By End User
11.14.1. Hospitals
11.14.2. Dermatology clinics
11.14.3. Ambulatory surgical centers
11.14.4. Others
11.15. France Keloid Treatment Market Forecast, By Treatment Type
11.15.1. Occlusive dressing
11.15.2. Compression therapy
11.15.3. Cryosurgery
11.15.4. Excision
11.15.5. Radiation therapy
11.15.6. Laser therapy
11.15.7. Interferon therapy
11.15.8. Intralesional corticosteroid injection
11.15.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
11.16. Italy Keloid Treatment Market Forecast, By End User
11.16.1. Hospitals
11.16.2. Dermatology clinics
11.16.3. Ambulatory surgical centers
11.16.4. Others
11.17. Italy Keloid Treatment Market Forecast, By Treatment Type
11.17.1. Occlusive dressing
11.17.2. Compression therapy
11.17.3. Cryosurgery
11.17.4. Excision
11.17.5. Radiation therapy
11.17.6. Laser therapy
11.17.7. Interferon therapy
11.17.8. Intralesional corticosteroid injection
11.17.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
11.18. Spain Keloid Treatment Market Forecast, By End User
11.18.1. Hospitals
11.18.2. Dermatology clinics
11.18.3. Ambulatory surgical centers
11.18.4. Others
11.19. Spain Keloid Treatment Market Forecast, By Treatment Type
11.19.1. Occlusive dressing
11.19.2. Compression therapy
11.19.3. Cryosurgery
11.19.4. Excision
11.19.5. Radiation therapy
11.19.6. Laser therapy
11.19.7. Interferon therapy
11.19.8. Intralesional corticosteroid injection
11.19.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
11.20. Rest of Europe Keloid Treatment Market Forecast, By End User
11.20.1. Hospitals
11.20.2. Dermatology clinics
11.20.3. Ambulatory surgical centers
11.20.4. Others
11.21. Rest of Europe Keloid Treatment Market Forecast, By Treatment Type
11.21.1. Occlusive dressing
11.21.2. Compression therapy
11.21.3. Cryosurgery
11.21.4. Excision
11.21.5. Radiation therapy
11.21.6. Laser therapy
11.21.7. Interferon therapy
11.21.8. Intralesional corticosteroid injection
11.21.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
11.22. Europe Keloid Treatment Market Attractiveness Analysis
11.22.1. By End User
11.22.2. By Treatment Type
11.23. PEST Analysis
11.24. Key Trends
11.25. Key Developments

12. Asia Pacific Keloid Treatment Market Analysis
12.1. Key Findings
12.2. Asia Pacific Keloid Treatment Market Overview
12.3. Asia Pacific Keloid Treatment Market Value Share Analysis, By End User
12.4. Asia Pacific Keloid Treatment Market Forecast, By End User
12.4.1. Hospitals
12.4.2. Dermatology clinics
12.4.3. Ambulatory surgical centers
12.4.4. Others
12.5. Asia Pacific Keloid Treatment Market Value Share Analysis, By Treatment Type
12.6. Asia Pacific Keloid Treatment Market Forecast, By Treatment Type
12.6.1. Occlusive dressing
12.6.2. Compression therapy
12.6.3. Cryosurgery
12.6.4. Excision
12.6.5. Radiation therapy
12.6.6. Laser therapy
12.6.7. Interferon therapy
12.6.8. Intralesional corticosteroid injection
12.6.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
12.7. Asia Pacific Keloid Treatment Market Value Share Analysis, by Country
12.8. Asia Pacific Keloid Treatment Market Forecast, by Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. ASEAN
12.8.5. Rest of Asia Pacific
12.9. Asia Pacific Keloid Treatment Market Analysis, by Country
12.10. China Keloid Treatment Market Forecast, By End User
12.10.1. Hospitals
12.10.2. Dermatology clinics
12.10.3. Ambulatory surgical centers
12.10.4. Others
12.11. China Keloid Treatment Market Forecast, By Treatment Type
12.11.1. Occlusive dressing
12.11.2. Compression therapy
12.11.3. Cryosurgery
12.11.4. Excision
12.11.5. Radiation therapy
12.11.6. Laser therapy
12.11.7. Interferon therapy
12.11.8. Intralesional corticosteroid injection
12.11.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
12.12. India Keloid Treatment Market Forecast, By End User
12.12.1. Hospitals
12.12.2. Dermatology clinics
12.12.3. Ambulatory surgical centers
12.12.4. Others
12.13. India Keloid Treatment Market Forecast, By Treatment Type
12.13.1. Occlusive dressing
12.13.2. Compression therapy
12.13.3. Cryosurgery
12.13.4. Excision
12.13.5. Radiation therapy
12.13.6. Laser therapy
12.13.7. Interferon therapy
12.13.8. Intralesional corticosteroid injection
12.13.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
12.14. Japan Keloid Treatment Market Forecast, By End User
12.14.1. Hospitals
12.14.2. Dermatology clinics
12.14.3. Ambulatory surgical centers
12.14.4. Others
12.15. Japan Keloid Treatment Market Forecast, By Treatment Type
12.15.1. Occlusive dressing
12.15.2. Compression therapy
12.15.3. Cryosurgery
12.15.4. Excision
12.15.5. Radiation therapy
12.15.6. Laser therapy
12.15.7. Interferon therapy
12.15.8. Intralesional corticosteroid injection
12.15.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid, and imiquimod)
12.16. ASEAN Keloid Treatment Market Forecast, By End User
12.16.1. Hospitals
12.16.2. Dermatology clinics
12.16.3. Ambulatory surgical centers
12.16.4. Others
12.17. ASEAN Keloid Treatment Market Forecast, By Treatment Type
12.17.1. Occlusive dressing
12.17.2. Compression therapy
12.17.3. Cryosurgery
12.17.4. Excision
12.17.5. Radiation therapy
12.17.6. Laser therapy
12.17.7. Interferon therapy
12.17.8. Intralesional corticosteroid injection
12.17.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid, and imiquimod)
12.18. Rest of Asia Pacific Keloid Treatment Market Forecast, By End User
12.18.1. Hospitals
12.18.2. Dermatology clinics
12.18.3. Ambulatory surgical centers
12.18.4. Others
12.19. Rest of Asia Pacific Keloid Treatment Market Forecast, By Treatment Type
12.19.1. Occlusive dressing
12.19.2. Compression therapy
12.19.3. Cryosurgery
12.19.4. Excision
12.19.5. Radiation therapy
12.19.6. Laser therapy
12.19.7. Interferon therapy
12.19.8. Intralesional corticosteroid injection
12.19.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
12.20. Asia Pacific Keloid Treatment Market Attractiveness Analysis
12.20.1. By End User
12.20.2. By Treatment Type
12.21. PEST Analysis
12.22. Key Trends
12.23. Key Developments

13. Middle East & Africa Keloid Treatment Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Keloid Treatment Market Overview
13.3. Middle East & Africa Keloid Treatment Market Value Share Analysis, By End User
13.4. Middle East & Africa Keloid Treatment Market Forecast, By End User
13.4.1. Hospitals
13.4.2. Dermatology clinics
13.4.3. Ambulatory surgical centers
13.4.4. Others
13.5. Middle East & Africa Keloid Treatment Market Value Share Analysis, By Treatment Type
13.6. Middle East & Africa Keloid Treatment Market Forecast, By Treatment Type
13.6.1. Occlusive dressing
13.6.2. Compression therapy
13.6.3. Cryosurgery
13.6.4. Excision
13.6.5. Radiation therapy
13.6.6. Laser therapy
13.6.7. Interferon therapy
13.6.8. Intralesional corticosteroid injection
13.6.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
13.7. Middle East & Africa Keloid Treatment Market Value Share Analysis, by Country
13.8. Middle East & Africa Keloid Treatment Market Forecast, by Country
13.8.1. GCC
13.8.2. South Africa
13.8.3. Rest of Middle East & Africa
13.9. Middle East & Africa Keloid Treatment Market Analysis, by Country
13.10. GCC Keloid Treatment Market Forecast, By End User
13.10.1. Hospitals
13.10.2. Dermatology clinics
13.10.3. Ambulatory surgical centers
13.10.4. Others
13.11. GCC Keloid Treatment Market Forecast, By Treatment Type
13.11.1. Occlusive dressing
13.11.2. Compression therapy
13.11.3. Cryosurgery
13.11.4. Excision
13.11.5. Radiation therapy
13.11.6. Laser therapy
13.11.7. Interferon therapy
13.11.8. Intralesional corticosteroid injection
13.11.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
13.12. South Africa Keloid Treatment Market Forecast, By End User
13.12.1. Hospitals
13.12.2. Dermatology clinics
13.12.3. Ambulatory surgical centers
13.12.4. Others
13.13. South Africa Keloid Treatment Market Forecast, By Treatment Type
13.13.1. Occlusive dressing
13.13.2. Compression therapy
13.13.3. Cryosurgery
13.13.4. Excision
13.13.5. Radiation therapy
13.13.6. Laser therapy
13.13.7. Interferon therapy
13.13.8. Intralesional corticosteroid injection
13.13.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
13.14. Rest of Middle East & Africa Keloid Treatment Market Forecast, By End User
13.14.1. Hospitals
13.14.2. Dermatology clinics
13.14.3. Ambulatory surgical centers
13.14.4. Others
13.15. Rest of Middle East & Africa Keloid Treatment Market Forecast, By Treatment Type
13.15.1. Occlusive dressing
13.15.2. Compression therapy
13.15.3. Cryosurgery
13.15.4. Excision
13.15.5. Radiation therapy
13.15.6. Laser therapy
13.15.7. Interferon therapy
13.15.8. Intralesional corticosteroid injection
13.15.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
13.16. Middle East & Africa Keloid Treatment Market Attractiveness Analysis
13.16.1. By End User
13.16.2. By Treatment Type
13.17. PEST Analysis
13.18. Key Trends
13.19. Key Developments

14. South America Keloid Treatment Market Analysis
14.1. Key Findings
14.2. South America Keloid Treatment Market Overview
14.3. South America Keloid Treatment Market Value Share Analysis, By End User
14.4. South America Keloid Treatment Market Forecast, By End User
14.4.1. Hospitals
14.4.2. Dermatology clinics
14.4.3. Ambulatory surgical centers
14.4.4. Others
14.5. South America Keloid Treatment Market Value Share Analysis, By Treatment Type
14.6. South America Keloid Treatment Market Forecast, By Treatment Type
14.6.1. Occlusive dressing
14.6.2. Compression therapy
14.6.3. Cryosurgery
14.6.4. Excision
14.6.5. Radiation therapy
14.6.6. Laser therapy
14.6.7. Interferon therapy
14.6.8. Intralesional corticosteroid injection
14.6.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
14.7. South America Keloid Treatment Market Value Share Analysis, by Country
14.8. South America Keloid Treatment Market Forecast, by Country
14.8.1. Brazil
14.8.2. Mexico
14.8.3. Rest of South America
14.9. South America Keloid Treatment Market Analysis, by Country
14.10. Brazil Keloid Treatment Market Forecast, By End User
14.10.1. Hospitals
14.10.2. Dermatology clinics
14.10.3. Ambulatory surgical centers
14.10.4. Others
14.11. Brazil Keloid Treatment Market Forecast, By Treatment Type
14.11.1. Occlusive dressing
14.11.2. Compression therapy
14.11.3. Cryosurgery
14.11.4. Excision
14.11.5. Radiation therapy
14.11.6. Laser therapy
14.11.7. Interferon therapy
14.11.8. Intralesional corticosteroid injection
14.11.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid, and imiquimod)
14.12. Mexico Keloid Treatment Market Forecast, By End User
14.12.1. Hospitals
14.12.2. Dermatology clinics
14.12.3. Ambulatory surgical centers
14.12.4. Others
14.13. Mexico Keloid Treatment Market Forecast, By Treatment Type
14.13.1. Occlusive dressing
14.13.2. Compression therapy
14.13.3. Cryosurgery
14.13.4. Excision
14.13.5. Radiation therapy
14.13.6. Laser therapy
14.13.7. Interferon therapy
14.13.8. Intralesional corticosteroid injection
14.13.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid, and imiquimod)
14.14. Rest of South America Keloid Treatment Market Forecast, By End User
14.14.1. Hospitals
14.14.2. Dermatology clinics
14.14.3. Ambulatory surgical centers
14.14.4. Others
14.15. Rest of South America Keloid Treatment Market Forecast, By Treatment Type
14.15.1. Occlusive dressing
14.15.2. Compression therapy
14.15.3. Cryosurgery
14.15.4. Excision
14.15.5. Radiation therapy
14.15.6. Laser therapy
14.15.7. Interferon therapy
14.15.8. Intralesional corticosteroid injection
14.15.9. Others (dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod)
14.16. South America Keloid Treatment Market Attractiveness Analysis
14.16.1. By End User
14.16.2. By Treatment Type
14.17. PEST Analysis
14.18. Key Trends
14.19. Key Developments

15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, Vehicles, and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A by Regions, Investment and Vehicles
15.2.3.2. M&A Key Players, Forward Integration and Backward Integration
15.3. Company Profiles: Key Players
15.3.1. Revitol Corporation Inc.
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Development Footprint
15.3.2. Xstrahl Medical
15.3.3. GlaxoSmithKline plc.
15.3.4. Bristol-Myers Squibb Company
15.3.5. Sensus Healthcare, Inc
15.3.6. Novartis AG, 
15.3.7. Bausch Health
15.3.8. Scarless Laboratories Inc.
15.3.9. Galena Biopharma, Inc.
15.3.10. RXi Pharmaceuticals, Inc.
15.3.11. Avita Medical
15.3.12. Perrigo Company
15.3.13. Soliton, Inc
15.3.14. Pacific World Corporation
15.3.15. Valeant Pharmaceuticals International Inc.
15.3.16. Sonoma Pharmaceuticals
15.3.17. Cynosure
15.3.18. Scar Heal
15.3.19. NewMedical Technology
15.3.20. Renovo Group plc.
16. Primary Key Insights
  • INQUIRE BEFORE BUYING